Preventing heart damage from cancer treatment
Part of Cancer, Heart & circulation clinical trials.
This trial tracks how cancer treatments affect the heart. It may help doctors find ways to prevent heart problems during your treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with cancer and your doctor plans to start treatment.
- You expect to live longer than one year from now.
- If you have newly diagnosed breast cancer and are getting a specific type of chemotherapy (anthracyclines), that is especially useful for this study.
- You must be able to understand and agree to participate in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the heart and blood vessels are working years after childhood cancer treatment with anthracycline chemotherapy, which can sometimes affect the heart. By checking your heart function, the study aims to find any early signs of problems so that better care can be provided.
This study tests a new tool that helps doctors figure out your risk for heart problems after cancer treatment. If you join, you'll get a heart risk check and possibly see a heart specialist. This could help prevent heart issues later.
This trial uses a special scoring system (ML Score) to predict if you might develop heart problems while receiving anthracycline chemotherapy or HER2-targeted therapies. It helps doctors decide on the best heart monitoring plan before starting treatment.
This study follows patients receiving a type of chemotherapy called anthracyclines to track how it affects the heart over time. The goal is to learn how to better protect heart health during cancer treatment.
This study tracks how well the heart handles HER2-targeted therapy (like Herceptin) during the first year of treatment for early-stage breast cancer. It helps keep you safe by checking heart function closely.
This study looks at whether doctors can predict heart problems caused by certain cancer treatments. It gathers information from patients before they start treatment to build better risk-checking tools.
Hear when a new Cancer Related Cardiovascular Toxicity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.